Ключевые слова
Аннотация
Rheumatoid arthritis is a chronic autoimmune disease that primarily affects the joints but can also involve internal organs, including the liver. Diffuse changes in liver echogenicity in rheumatoid arthritis patients are often asymptomatic, yet they play a crucial role in assessing disease progression and treatment outcomes. Traditional diagnostic methods, such as laboratory tests and liver biopsy, are invasive and may cause patient discomfort. Ultrasound examination provides a safe, non-invasive, and effective method to detect diffuse hepatic changes.
Early identification of these changes allows for timely preventive interventions, reduces the risk of complications, and supports individualized treatment strategies. Integrating ultrasound monitoring into routine care for rheumatoid arthritis patients enhances both liver health and overall therapeutic effectiveness.
Библиографические ссылки
Firestein, G. S., Budd, R. C., Gabriel, S. E., McInnes, I. B., & O’Dell, J. R. (2017). Kelley and Firestein’s Textbook of Rheumatology (10th ed.). Philadelphia: Elsevier.
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023–2038.
Zhang, W., & McInnes, I. B. (2019). Liver involvement in rheumatoid arthritis: Pathophysiology and clinical management. Clinical Reviews in Allergy & Immunology, 57(3), 345–359.
Filippucci, E., Di Geso, L., & Grassi, W. (2015). Ultrasound imaging for the evaluation of liver involvement in systemic autoimmune diseases. Best Practice & Research Clinical Rheumatology, 29(5), 727–740.
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., … Sanyal, A. J. (2018). The diagnosis and management of non-alcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328–357.